{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:05:35Z","timestamp":1783911935320,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018217","name":"Universidade Federal De S\u00e3o Paulo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018217","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Assessment of response to neoadjuvant chemotherapy in pediatric osteosarcoma is challenging, as histologic evaluation of tumor necrosis is only available after surgical resection. Quantitative MRI parameters, including diffusion-weighted imaging (DWI)\u2013derived apparent diffusion coefficient (ADC) values, tumor volume, and radiologic necrosis, may provide noninvasive information related to treatment response and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate quantitative MRI features before and after neoadjuvant chemotherapy in pediatric osteosarcoma and to investigate their associations with histologic response and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective single-center cohort study included 50 pediatric patients with histologically confirmed osteosarcoma (2014\u20132023) who underwent MRI with DWI at diagnosis and after neoadjuvant chemotherapy. Tumor volume, radiologic necrosis, and ADC parameters (minimum, mean, and maximum) were independently assessed by two musculoskeletal radiologists. Histologic response was graded using the Huvos system. Associations between imaging parameters and histologic response, survival outcomes, and relapse were evaluated using nonparametric and exploratory time-to-event analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifty pediatric patients were included (mean age 13.2\u00a0years; 62% male), of whom 21% had metastatic disease at diagnosis. Pre-treatment ADC minimum differed between good and poor histologic responders (median 661.75 vs 851.0\u00d710\u207b\u2076 mm\n                      <jats:sup>2<\/jats:sup>\n                      \/s;\n                      <jats:italic>P<\/jats:italic>\n                      =0.047). Tumor volume variation showed evidence of association with Huvos grade (Spearman\n                      <jats:italic>\u03c1<\/jats:italic>\n                      =\u22120.402,\n                      <jats:italic>P<\/jats:italic>\n                      =0.004). Post-treatment tumor volume was associated with clinical outcome (\n                      <jats:italic>P<\/jats:italic>\n                      =0.005), and larger pre- and post-treatment volumes were observed in patients who relapsed. All ADC parameters increased after chemotherapy (\n                      <jats:italic>P<\/jats:italic>\n                      &lt;0.01). Pre-treatment ADC minimum showed evidence of association with overall survival (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      =\u22120.300,\n                      <jats:italic>P<\/jats:italic>\n                      =0.038), while post-treatment ADC minimum was associated with disease-free survival (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      =\u22120.458,\n                      <jats:italic>P<\/jats:italic>\n                      =0.028). ROC analysis of pre-treatment ADC minimum yielded an AUC of 0.68 for histologic response.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Quantitative MRI parameters demonstrate exploratory associations with histologic response and clinical outcomes in pediatric osteosarcoma, providing additional information when interpreted alongside conventional MRI features and clinical data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00247-026-06665-4","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:37:56Z","timestamp":1779525476000},"page":"1572-1587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiparametric MRI biomarkers in pediatric osteosarcoma: associations of ADC, necrosis, and tumor volume with histologic and clinical outcomes in a retrospective cohort study"],"prefix":"10.1007","volume":"56","author":[{"given":"Isabela Azevedo Nicodemos da","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Marie","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Renata Pacheco Donato","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Tarso Kawakami","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Batista Rosa","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Henrique de","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Grassato de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Manoel","family":"Lederman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur Rocha Corr\u00eaa","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falio Brand\u00e3o","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"6665_CR1","unstructured":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. U.S (2025) Cancer statistics working group. U.S. cancer statistics data visualizations tool. [Internet]. Available from: https:\/\/www.cdc.gov\/cancer\/dataviz.\u00a0Accessed 6 June 2025"},{"key":"6665_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1345576","volume":"14","author":"L Zhang","year":"2024","unstructured":"Zhang L, Gao Q, Dou Y et al (2024) Evaluation of the neoadjuvant chemotherapy response in osteosarcoma using the MRI DWI-based machine learning radiomics nomogram. Front Oncol 14:1345576. https:\/\/doi.org\/10.3389\/fonc.2024.1345576","journal-title":"Front Oncol"},{"key":"6665_CR3","unstructured":"The American Cancer Society medical and editorial content team (2025) Survival rates for osteosarcoma [Internet]. Available from: https:\/\/www.cancer.org\/cancer\/types\/osteosarcoma\/detection-diagnosis-staging\/survival-rates.html.\u00a0Accessed 6 Sept 2025"},{"key":"6665_CR4","unstructured":"National Comprehensive Cancer Network (2025) Bone cancer - NCCN practice guidelines in oncology [Guideline] [Internet]. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/bone.pdf.\u00a0Accessed 9 June 2025"},{"key":"6665_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-022-01177-9","volume":"13","author":"EJ Inarejos Clemente","year":"2022","unstructured":"Inarejos Clemente EJ, Navarro OM, Navallas M et al (2022) Multiparametric MRI evaluation of bone sarcomas in children. Insights Imaging 13:33. https:\/\/doi.org\/10.1186\/s13244-022-01177-9","journal-title":"Insights Imaging"},{"key":"6665_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259564","volume":"17","author":"KY Teo","year":"2022","unstructured":"Teo KY, Daescu O, Cederberg K et al (2022) Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: predicting tumor response to chemotherapy. PLoS One 17:e0259564","journal-title":"PLoS One"},{"key":"6665_CR7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1148\/radiol.12111740","volume":"265","author":"LM Fayad","year":"2012","unstructured":"Fayad LM, Jacobs MA, Wang X et al (2012) Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques. Radiology 265:340\u201356. https:\/\/doi.org\/10.1148\/radiol.12111740","journal-title":"Radiology"},{"key":"6665_CR8","doi-asserted-by":"crossref","unstructured":"Bacci G, Longhi A, Versari M et al (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106:1154\u20131161","DOI":"10.1002\/cncr.21724"},{"key":"6665_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinimag.2017.08.003","volume":"47","author":"AJ Degnan","year":"2018","unstructured":"Degnan AJ, Chung CY, Shah AJ (2018) Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors. Clin Imaging 47:9\u201313","journal-title":"Clin Imaging"},{"key":"6665_CR10","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2214\/AJR.06.1403","volume":"188","author":"DM Koh","year":"2007","unstructured":"Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol 188:1622\u20131635","journal-title":"Am J Roentgenol"},{"key":"6665_CR11","doi-asserted-by":"crossref","unstructured":"Liu C, Xi Y, Li M et al (2019) Monitoring response to neoadjuvant chemotherapy of primary osteosarcoma using diffusion kurtosis magnetic resonance imaging: initial findings. Korean J Radiol 20:801. https:\/\/doi.org\/10.3348\/kjr.2018.0453","DOI":"10.3348\/kjr.2018.0453"},{"key":"6665_CR12","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1148\/rg.2016160056","volume":"36","author":"BY Chan","year":"2016","unstructured":"Chan BY, Gill KG, Rebsamen SL, Nguyen JC (2016) MR imaging of pediatric bone marrow. RadioGraphics 36:1911\u201330. https:\/\/doi.org\/10.1148\/rg.2016160056","journal-title":"RadioGraphics"},{"key":"6665_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/00003086-200007000-00027","volume":"376","author":"KH Shin","year":"2000","unstructured":"Shin KH, Moon SH, Suh JS, Yang WI (2000) Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma. Clin Orthop Relat Res 376:200\u20138. https:\/\/doi.org\/10.1097\/00003086-200007000-00027","journal-title":"Clin Orthop Relat Res"},{"key":"6665_CR14","doi-asserted-by":"crossref","unstructured":"Oka K, Yakushiji T, Sato H et al (2010) The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol 39:141\u2013146","DOI":"10.1007\/s00256-009-0830-7"},{"key":"6665_CR15","doi-asserted-by":"publisher","unstructured":"De Tarso Kawakami Perez P, Fayad LM, Rosa Pinto MB et al (2025) Multiparametric assessment of high-grade pediatric soft-tissue sarcomas with anatomic and functional MRI sequences: a retrospective study. Skeletal Radiol. https:\/\/doi.org\/10.1007\/s00256-025-05025-x","DOI":"10.1007\/s00256-025-05025-x"},{"key":"6665_CR16","doi-asserted-by":"publisher","first-page":"W790","DOI":"10.2214\/AJR.10.5979","volume":"196","author":"M Horger","year":"2011","unstructured":"Horger M, Weisel K, Horger W et al (2011) Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: Preliminary results. AJR Am J Roentgenol 196:W790-5. https:\/\/doi.org\/10.2214\/AJR.10.5979","journal-title":"AJR Am J Roentgenol"},{"key":"6665_CR17","doi-asserted-by":"crossref","unstructured":"Saleh MM, Abdelrahman TM, Madney Y, Mohamed G, Shokry AM, Moustafa AF (2020Nov 1) Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing\u2019s sarcoma. BJR 93:20200257","DOI":"10.1259\/bjr.20200257"},{"key":"6665_CR18","doi-asserted-by":"publisher","unstructured":"Asmar K, Saade C, Salman R et al (2020) The value of diffusion weighted imaging and apparent diffusion coefficient in primary osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience. Eur J Radiol 124:108855. https:\/\/doi.org\/10.1016\/j.ejrad.2020.108855","DOI":"10.1016\/j.ejrad.2020.108855"},{"key":"6665_CR19","doi-asserted-by":"crossref","unstructured":"Wang CS, Du LJ, Si MJ et al (2013) Noninvasive assessment of response to neoadjuvant chemotherapy in osteosarcoma of long bones with diffusion-weighted imaging: An initial in vivo study. PLoS One 8:e72679. https:\/\/doi.org\/10.1371\/journal.pone.0072679","DOI":"10.1371\/journal.pone.0072679"},{"key":"6665_CR20","doi-asserted-by":"crossref","unstructured":"Yu H, Gao L, Shi R, Kong M, Duan L, Cui J (2023Jun) Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma. Quant Imaging Med Surg 13:3716\u20133725","DOI":"10.21037\/qims-22-1095"},{"key":"6665_CR21","doi-asserted-by":"crossref","unstructured":"Uhl M, Saueressig U, Koehler G, Kontny U, Niemeyer C, Reichardt W et al (2006Nov 10) Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas. Pediatr Radiol 36:1306\u20131311","DOI":"10.1007\/s00247-006-0324-x"},{"key":"6665_CR22","doi-asserted-by":"crossref","unstructured":"Baunin C, Schmidt G, Baumstarck K, Bouvier C, Gentet JC, Aschero A et al (2012Sep) Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results. Skeletal Radiol 41:1141\u20131149","DOI":"10.1007\/s00256-012-1360-2"},{"key":"6665_CR23","doi-asserted-by":"crossref","unstructured":"Byun BH, Kong CB, Lim I et al (2013) Combination of18 F-FDG PET\/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma. J Nucl Med 54:1053\u20139. https:\/\/doi.org\/10.2967\/jnumed.112.115964","DOI":"10.2967\/jnumed.112.115964"},{"key":"6665_CR24","doi-asserted-by":"crossref","unstructured":"Habre C, Dabadie A, Loundou AD et al (2021) Diffusion-weighted imaging in differentiating mid-course responders to chemotherapy for long-bone osteosarcoma compared to the histologic response: an update. Pediatr Radiol 51:1714\u201323. https:\/\/doi.org\/10.1007\/s00247-021-05037-4","DOI":"10.1007\/s00247-021-05037-4"},{"key":"6665_CR25","doi-asserted-by":"crossref","unstructured":"Lee SK, Jee WH, Jung CK et al (2020) Prediction of poor responders to neoadjuvant chemotherapy in patients with osteosarcoma: additive value of diffusion-weighted MRI including volumetric analysis to standard MRI at 3T. PLoS One 15:e0229983","DOI":"10.1371\/journal.pone.0229983"},{"key":"6665_CR26","doi-asserted-by":"crossref","unstructured":"Hayashida Y, Yakushiji T, Awai K et al (2006) Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 16:2637\u20132643","DOI":"10.1007\/s00330-006-0342-y"},{"key":"6665_CR27","doi-asserted-by":"crossref","unstructured":"Hao Y, An R, Xue Y et al (2021) Prognostic value of tumoral and peritumoral magnetic resonance parameters in osteosarcoma patients for monitoring chemotherapy response. Eur Radiol 31:3518\u201329. https:\/\/doi.org\/10.1007\/s00330-020-07338-y","DOI":"10.1007\/s00330-020-07338-y"},{"key":"6665_CR28","doi-asserted-by":"crossref","unstructured":"Alsharief AN, Martinez-Rios C, Hopyan S et al (2019) Usefulness of diffusion-weighted MRI in the initial assessment of osseous sarcomas in children and adolescents. Pediatr Radiol 49:1201\u20131208","DOI":"10.1007\/s00247-019-04436-y"},{"key":"6665_CR29","doi-asserted-by":"crossref","unstructured":"Tirtei E, Michelsen SW, Haveman LM et al (2025) Prognostic factors in newly diagnosed high\u2010grade osteosarcoma\u2014a systematic review. Cancer Med 14:e71044. https:\/\/doi.org\/10.1002\/cam4.71044","DOI":"10.1002\/cam4.71044"},{"key":"6665_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.radi.2022.04.008","volume":"28","author":"O Yildirim","year":"2022","unstructured":"Yildirim O, Al Khatalin M, Kargin OA, Camurdan VB (2022) MRI for evaluation of preoperative chemotherapy in osteosarcoma. Radiography 28:593\u2013604. https:\/\/doi.org\/10.1016\/j.radi.2022.04.008","journal-title":"Radiography"},{"key":"6665_CR31","doi-asserted-by":"crossref","unstructured":"Bajpai J, Gamnagatti S, Kumar R et al (2011) Role of MRI in osteosarcoma for evaluation and prediction of chemotherapy response: correlation with histological necrosis. Pediatr Radiol 41:441\u201350. https:\/\/doi.org\/10.1007\/s00247-010-1876-3","DOI":"10.1007\/s00247-010-1876-3"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-026-06665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00247-026-06665-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-026-06665-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T02:59:19Z","timestamp":1783911559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00247-026-06665-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["6665"],"URL":"https:\/\/doi.org\/10.1007\/s00247-026-06665-4","relation":{},"ISSN":["1432-1998"],"issn-type":[{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}